Skip to main content
. 2017 Jul 12;8:16037. doi: 10.1038/ncomms16037

Figure 5. De-repression of Etv5 promotes TFH cell differentiation in Cic-deficient CD4+T cells.

Figure 5

(a) qRT-PCR analysis for levels of Pea3 group genes in splenic CD4+ T cells from Cicf/f (WT) and Cicf/fCd4-Cre (cKO) mice. n=3 per each genotype. (b) Chromatin immunoprecipitation (ChIP)-qPCR analysis showing CIC promoter occupancy of Etv4 and Etv5 in CD4+ T cells. CD4+ T cells purified from spleen of Cicf/f and Cicf/fCd4-Cre mice were used. n=3 per each genotype. (c) qRT-PCR analysis for levels of Etv4 and Etv5 in sorted CD4+PD-1CXCR5 non-TFH and CD4+PD-1+CXCR5+ TFH cells. Splenocytes from 5 to 6 Cicf/f mice or 3 to 4 Cicf/fCd4-Cre mice were pooled and subjected to cell sorting. Three independent experiments were conducted. (d) Western blot analysis for levels of ETV4 and ETV5 in sorted splenic CD4+PD-1+CXCR5+ TFH cells. The dash lines on blot images indicate cropping without image manipulation to either side. Three independent experiments were conducted. The graphs in ad show data as mean±s.e.m. *P<0.05 and **P<0.01 (two-tailed two-sample unequal variance Student t-test). (e) Western blot analysis for levels of CIC and ETV5 in sorted non-TFH and TFH cells from spleen of WT C57BL/6 (B6) mice. The images are representative of two independent experiments. (f) Thy1.1+ OT-II cells infected with control or ETV5-expressing retrovirus were adoptively transferred to Thy1.2+ B6 recipient mice. Eight days after immunization with NP-OVA in alum, donor cells were analysed for TFH cell differentiation using flow cytometry. Control-RV, n=12; ETV5-RV, n=9. ***P<0.001 (two-tailed two-sample unequal variance Student t-test). (g) Thy1.1+ OT-II cells infected with control (shNC) or Etv5 shRNA (shETV5) expressing retrovirus were subjected to adoptive transfer experiment. Eight days after immunization, donor cells were analysed for TFH cell differentiation. shNC, n=6; shETV5, n=8. **P<0.01 (two-tailed two-sample unequal variance Student t-test). (h) WT and Cic cKO OT-II cells were prepared from spleens of Thy1.1+ OT-II Cicf/f and Thy1.1+ OT-II Cicf/fCd4-Cre mice, respectively. WT OT-II cells infected with shNC retrovirus and Cic cKO OT-II cells infected with shNC or shETV5-expressing retrovirus were transferred into Thy1.2+ B6 recipient mice. Seven days after immunization with NP-OVA in alum, donor cells were analysed for TFH cell differentiation. WT:shNC, n=9; cKO:shNC, n=6; cKO:shETV5, n=6. ***P<0.001 (two-tailed two-sample unequal variance Student t-test).